Cellular immune responses after successful hepatitis B immunization in patients transplanted for HBV-related diseases: Existence of HBsAg-specific regulatory T cells
T Bauer, M Günther, U Bienzle, W Jilg · Zeitschrift für Gastroenterologie · 2006 · Heft 01
Bibliografische Angaben
Zusammenfassung
Patients after liver transplantation for hepatitis B related diseases are currently treated lifelong with hepatitis B immunoglobulin to prevent endogenous reinfection with hepatitis B virus (HBV). Active immunization with hepatitis B vaccine would be a preferable alternative; however, most attempts to immunize these patients with standard vaccine failed. A study with a new adjuvanted hepatitis B vaccine (HBsAg-AS02) was exceptionally successful leading to a hightitered longlasting antibody response in 80% of all vaccinees (Bienzle et al., Hepatology. 2003 Oct;38(4): 811–9). In a continuative study we analysed ce…